Northern Trust Corp Terns Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 463,875 shares of TERN stock, worth $3.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

463,875

Previous 347,767 33.39%

Holding current value

$3.08 Million

Previous $2.37 Million 63.34%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.49 - $10.8 $753,540 - $1.25 Million	116,108 Added 33.39%	463,875 $3.87 Million
Q2 2024 Aug 14, 2024	SELL	$4.54 - $8.2 $36,451 - $65,837	-8,029 Reduced 2.26%	347,767 $2.37 Million
Q1 2024 May 14, 2024	SELL	$4.86 - $8.19 $13,160 - $22,178	-2,708 Reduced 0.76%	355,796 $2.33 Million
Q4 2023 Feb 13, 2024	BUY	$3.37 - $6.86 $34,320 - $69,862	10,184 Added 2.92%	358,504 $2.33 Million
Q3 2023 Nov 13, 2023	SELL	$4.7 - $8.55 $62,486 - $113,672	-13,295 Reduced 3.68%	348,320 $1.75 Million
Q2 2023 Aug 11, 2023	BUY	$7.35 - $13.29 $2.25 Million - $4.07 Million	306,536 Added 556.54%	361,615 $3.16 Million
Q1 2023 May 15, 2023	BUY	$7.91 - $12.0 $185,774 - $281,832	23,486 Added 74.34%	55,079 $652,000
Q4 2022 Feb 13, 2023	BUY	$4.62 - $10.18 $46,611 - $102,706	10,089 Added 46.92%	31,593 $321,000
Q3 2022 Nov 14, 2022	BUY	$1.87 - $6.42 $13,334 - $45,781	7,131 Added 49.61%	21,504 $127,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.0 $135,673 - $271,347	-90,449 Reduced 86.29%	14,373 $36,000
Q1 2022 May 13, 2022	SELL	$2.83 - $6.7 $20,415 - $48,333	-7,214 Reduced 6.44%	104,822 $311,000
Q4 2021 Feb 08, 2022	SELL	$5.65 - $10.73 $27,572 - $52,362	-4,880 Reduced 4.17%	112,036 $792,000
Q3 2021 Nov 15, 2021	BUY	$7.22 - $13.46 $217,560 - $405,590	30,133 Added 34.72%	116,916 $1.22 Million
Q2 2021 Aug 13, 2021	SELL	$12.26 - $22.0 $61,349 - $110,088	-5,004 Reduced 5.45%	86,783 $1.06 Million
Q1 2021 May 12, 2021	BUY	$17.13 - $27.25 $1.57 Million - $2.5 Million	91,787 New	91,787 $2.02 Million

Others Institutions Holding TERN

# of Institutions

163

Shares Held

78.4M

Call Options Held

450K

Put Options Held

423K

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $250M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Terns Pharmaceuticals, Inc. Transaction History